妊娠35-37周胎盘形成受损生物标志物对不良围产结局的预测
前瞻性观察19 209例单胎妊娠,于35+0至36+6周测量子宫动脉搏动指数及血清PlGF、sFlt-1,评估其对死产、可疑胎儿窘迫剖宫产、新生儿死亡或缺氧缺血性脑病、新生儿病房住院≥48小时的预测价值;结论为这些指标在小于胎龄儿和非小于胎龄儿中预测效能均差。
要点
- 83%死产、82%可疑胎儿窘迫剖宫产、91%新生儿死亡或缺氧缺血性脑病、86%新生儿病房住院≥48小时发生于非小于胎龄儿。
- 子宫动脉搏动指数>95百分位、sFlt-1>95百分位、PlGF<5百分位与可疑胎儿窘迫剖宫产及新生儿病房住院≥48小时风险增加相关。
- 多变量回归显示生物标志物对可疑胎儿窘迫剖宫产无显著预测贡献,对新生儿病房住院≥48小时的预测仅边际改善。
核心结论
- 在35-37周常规产前评估中,子宫动脉搏动指数、sFlt-1或PlGF对小于胎龄儿和非小于胎龄儿的不良围产结局预测效能均差。
研究设计与样本
- 前瞻性观察研究,纳入19 209例单胎妊娠,于35+0至36+6周进行常规医院访视。
- 访视内容包括记录母亲人口学特征和病史、超声估计胎儿体重、彩色多普勒测量平均子宫动脉搏动指数、测定血清PlGF和sFlt-1浓度。
- 采用多变量逻辑回归分析确定各因素对四种不良结局的预测贡献,并用预测概率构建受试者工作特征曲线评估筛查效能。
诊断标准与关键数值
- 子宫动脉搏动指数>95百分位、sFlt-1>95百分位和PlGF<5百分位与可疑胎儿窘迫剖宫产及新生儿病房住院≥48小时风险增加相关。
- 死产和新生儿死亡或缺氧缺血性脑病病例数过少,无法证明与无这些不良结局者之间存在显著差异。
- 多变量逻辑回归分析显示,在预测可疑胎儿窘迫剖宫产时生物标志物无显著贡献;母亲人口学特征和病史对新生儿病房住院≥48小时的预测仅被sFlt-1或PlGF边际改善。
- 每种生物标志物对不良结局的检出率在小于胎龄儿中高于非小于胎龄儿,但伴随假阳性率增加。
- 子宫动脉搏动指数>95百分位、sFlt-1>95百分位和PlGF<5百分位对大多数不良结局的相对风险在小于胎龄儿和非小于胎龄儿中均<2.5。
局限性
- 死产和新生儿死亡或缺氧缺血性脑病病例数过少,无法证明与无这些不良结局者之间存在显著差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the potential value of uterine artery pulsatility index (UtA-PI) and serum levels of the angiogenic placental growth factor (PlGF) and the antiangiogenic factor soluble fms-like tyrosine kinase-1 (sFlt-1) in the prediction of adverse perinatal outcome in small-for-gestational-age (SGA) and non-SGA neonates at 35-37 weeks' gestation.
METHODS: This was a prospective observational study of 19 209 singleton pregnancies attending for a routine hospital visit at 35 + 0 to 36 + 6 weeks' gestation. This visit included recording of maternal demographic characteristics and medical history, sonographic estimation of fetal weight, color Doppler ultrasound for measurement of mean UtA-PI, and measurement of serum concentrations of PlGF and sFlt-1. Multivariable logistic regression analysis was carried out to determine which of the factors from maternal or pregnancy characteristics and measurements of UtA-PI, PlGF and sFlt-1 provided a significant contribution in the prediction of each of four adverse outcome measures: first, stillbirth; second, Cesarean delivery for suspected fetal compromise in labor; third, neonatal death or hypoxic ischemic encephalopathy Grade 2 or 3; and, fourth, admission to the neonatal unit (NNU) for ≥ 48 h. Predicted probabilities from logistic regression analysis were used to construct receiver-operating characteristics curves to assess the performance of screening for these adverse outcomes.
RESULTS: First, 83% of stillbirths, 82% of Cesarean sections for presumed fetal compromise in labor, 91% of cases of neonatal death or hypoxic ischemic encephalopathy and 86% of NNU admissions for ≥ 48 h occurred in pregnancies with a non-SGA neonate. Second, UtA-PI > 95th percentile, sFlt-1 > 95th percentile and PlGF < 5th percentile were associated with increased risk of Cesarean delivery for suspected fetal compromise in labor and NNU admission for ≥ 48 h; the number of stillbirths and cases of neonatal death or hypoxic ischemic encephalopathy was too small to demonstrate significance in the observed differences from cases without these adverse outcomes. Third, multivariable logistic regression analysis demonstrated that, in the prediction of Cesarean delivery for suspected fetal compromise in labor, there was no significant contribution from biomarkers; the prediction of NNU admission for ≥ 48 h by maternal demographic characteristics and medical history was only marginally improved by the addition of sFlt-1 or PlGF. Fourth, for each biomarker, the detection rate of adverse outcome was higher in SGA than in non-SGA neonates, but this increase was accompanied by an increase in false-positive rate. Fifth, the relative risk of UtA-PI > 95th , sFlt-1 > 95th and PlGF < 5th percentiles for most adverse outcomes was < 2.5 in both SGA and non-SGA neonates.
CONCLUSIONS: In pregnancies undergoing routine antenatal assessment at 35-37 weeks' gestation, measurements of UtA-PI, sFlt-1 or PlGF provide poor prediction of adverse perinatal outcome in both SGA and non-SGA fetuses. Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.
引用
- Ciobanou A, Jabak S, De Castro H, et al. Biomarkers of impaired placentation at 35-37 weeks' gestation in the prediction of adverse perinatal outcome. Ultrasound Obstet Gynecol. 2019. PMID: 31100188. doi:10.1002/uog.20346
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。